MBIA (MBI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
Annual meeting scheduled for May 5, 2026, will be held virtually to ensure universal access for all shareholders.
Shareholders will vote on the election of six directors, an advisory say-on-pay for executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for 2026.
Proxy materials are available online, and shareholders can vote via internet, phone, mail, or during the live webcast.
A quorum requires participation by holders of a majority of outstanding shares; each share equals one vote.
Voting matters and shareholder proposals
Proposal 1: Election of six directors for a one-year term expiring at the 2027 annual meeting.
Proposal 2: Advisory vote on executive compensation as disclosed in the proxy statement.
Proposal 3: Ratification of PricewaterhouseCoopers LLP as independent auditors for 2026.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of a significant majority of independent directors, with separate Chairman and CEO roles.
Board committees: Executive, Finance and Risk, Compensation and Governance, and Audit, each with defined charters and responsibilities.
Directors are expected to attend at least 75% of meetings; all met this requirement in 2025.
Board diversity is emphasized, considering a range of skills, backgrounds, and personal characteristics.
Shareholders may recommend director nominees; no shareholder nominees in 2025.
Latest events from MBIA
- 2025 net losses narrowed, PREPA exposure reduced, and investor call set for February 27, 2026.MBI
Q4 202527 Feb 2026 - Q3 2024 net loss narrowed to $56M, but PREPA risks and negative book value persist.MBI
Q3 202412 Feb 2026 - 2024 net loss narrowed, but adjusted losses rose and PREPA uncertainty persists.MBI
Q4 202412 Feb 2026 - Q2 net loss hit $254M on PREPA charges; book value fell to negative $39.07.MBI
Q2 20242 Feb 2026 - Annual meeting to vote on directors, pay, auditors, and incentive plan; board is majority independent.MBI
Proxy Filing2 Dec 2025 - Net loss narrowed, PREPA claim marketability improved, but litigation uncertainty persists.MBI
Q2 202523 Nov 2025 - Q1 2025 net loss narrows, PREPA risk remains, statutory capital and liquidity strong.MBI
Q1 202520 Nov 2025 - Q3 net loss narrowed on PREPA claim sales; strong capital and liquidity support future returns.MBI
Q3 202513 Nov 2025